Draegerwerk AG & Co KGaA Preference Shares (DRW3) Received a €52.00 Target Price at Deutsche Bank

Draegerwerk AG & Co KGaA Preference Shares (DRW3) Received a €52.00 Target Price at Deutsche Bank

Draegerwerk AG & Co KGaA Preference Shares (ETR:DRW3) has been given a €52.00 ($60.47) price target by analysts at Deutsche Bank in a research report issued on Tuesday. The brokerage currently has a “neutral” rating on the stock. Deutsche Bank’s price target indicates a potential upside of 1.07% from the company’s previous close.

Several other equities analysts have also commented on DRW3. Warburg Research set a €75.00 ($87.21) price target on shares of Draegerwerk AG & Co KGaA Preference Shares and gave the company a “neutral” rating in a research note on Monday, July 16th. Independent Research set a €68.00 ($79.07) price target on shares of Draegerwerk AG & Co KGaA Preference Shares and gave the company a “neutral” rating in a research note on Tuesday, July 17th. Hauck & Aufhaeuser set a €55.00 ($63.95) price target on shares of Draegerwerk AG & Co KGaA Preference Shares and gave the company a “sell” rating in a research note on Monday, July 23rd. HSBC set a €54.00 ($62.79) price target on shares of Draegerwerk AG & Co KGaA Preference Shares and gave the company a “sell” rating in a research note on Thursday, July 26th. Finally, Nord/LB set a €72.00 ($83.72) price target on shares of Draegerwerk AG & Co KGaA Preference Shares and gave the company a “neutral” rating in a research note on Monday, September 10th. Three equities research analysts have rated the stock with a sell rating and seven have issued a hold rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of €59.61 ($69.32).

Shares of Draegerwerk AG & Co KGaA Preference Shares stock opened at €51.45 ($59.83) on Tuesday. Draegerwerk AG & Co KGaA Preference Shares has a 52 week low of €69.80 ($81.16) and a 52 week high of €107.00 ($124.42).

About Draegerwerk AG & Co KGaA Preference Shares

Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Featured Story: Capital Gains

Related posts

Leave a Comment